Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysis
Pierre Blanchard(Inserm), Steven J. Frank(The University of Texas MD Anderson Cancer Center), Emma B. Holliday(The University of Texas MD Anderson Cancer Center), G. Brandon Gunn(The University of Texas MD Anderson Cancer Center), X Zhu(The University of Texas MD Anderson Cancer Center), David I. Rosenthal(The University of Texas MD Anderson Cancer Center), Radhe Mohan(The University of Texas MD Anderson Cancer Center), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Adam S. Garden(The University of Texas MD Anderson Cancer Center), Nikhil G. Thaker, Joseph Crutison(The University of Texas MD Anderson Cancer Center), Mike Hernández(The University of Texas MD Anderson Cancer Center), Abdallah Mohamed(The University of Texas MD Anderson Cancer Center), Rong Ye(The University of Texas MD Anderson Cancer Center), Erich M. Sturgis(The University of Texas MD Anderson Cancer Center), Merrill S. Kies(The University of Texas MD Anderson Cancer Center), William H. Morrison(The University of Texas MD Anderson Cancer Center)
Cited by 231
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation
|International Journal of Radiation Oncology*Biology*Physics|1995|458
Head and Neck Cancers
|Journal of the National Comprehensive Cancer Network|2011|415
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
|Radiotherapy and Oncology|2017|374